Cell:革兰氏阴性菌诱发炎症反应机制新解

2012-07-27 songbo 生物谷

7月20日,Cell杂志在线报道,革兰氏阴性菌感染通过TRIF信号途径激活NLRP3炎症小体,诱导炎症反应。 由于可引发"败血症综合征",一种全身性难以控制的炎症反应,革兰氏阴性菌全身性感染以高死亡率著称。虽然大家公认革兰氏阴性细菌感染的免疫反应始于Toll样受体4对内毒素的识别,但革兰氏阴性菌血症过程中发生的炎症反应的分子机制仍不清楚。 本研究揭示了一个TRIF(含TIR结构域的诱导β-干扰


7月20日,Cell杂志在线报道,革兰氏阴性菌感染通过TRIF信号途径激活NLRP3炎症小体,诱导炎症反应。

由于可引发"败血症综合征",一种全身性难以控制的炎症反应,革兰氏阴性菌全身性感染以高死亡率著称。虽然大家公认革兰氏阴性细菌感染的免疫反应始于Toll样受体4对内毒素的识别,但革兰氏阴性菌血症过程中发生的炎症反应的分子机制仍不清楚。

本研究揭示了一个TRIF(含TIR结构域的诱导β-干扰素适配器,是一类可响应激活的Toll样受体的适配器)信号途径。所有革兰氏阴性菌均通过这一途径激活NLRP3炎症小体(NLRP3是PRR大家族中Nod样受体亚家族成员之一,在激活之后能够通过与接头蛋白相互作用,活化半胱氨酸蛋白酶-1(caspase-1),形成蛋白复合物"炎症小体")。

通过TRIF,革兰氏阴性菌激活caspase-11。 TRIF通过I型干扰素的信号激活caspase-11,是caspase-11诱导和自我激活必要充分条件。 Caspase-11随后与组装好的NLRP3炎症小体协同调节caspase-1的激活,并导致不依赖于caspase-1的细胞死亡。这些事件尤其是发生在革兰氏阴性菌,而不是革兰氏阳性菌感染的情况下。

证实TRIF对caspase-11的调节作用突出表明,在革兰氏阴性细菌感染时,作为炎症小体的主要调节者,Toll样受体发挥重要作用。

doi:10.1016/j.cell.2011.10.017
PMC:
PMID:

TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria

Vijay A.K. Rathinam, Sivapriya Kailasan Vanaja, Lisa Waggoner, Anna Sokolovska, Christine Becker, Lynda M. Stuart, John M. Leong, Katherine A. Fitzgerald

Systemic infections with Gram-negative bacteria are characterized by high mortality rates due to the sepsis syndrome, a widespread and uncontrolled inflammatory response. Though it is well recognized that the immune response during Gram-negative bacterial infection is initiated after the recognition of endotoxin by Toll-like receptor 4, the molecular mechanisms underlying the detrimental inflammatory response during Gram-negative bacteremia remain poorly defined. Here, we identify a TRIF pathway that licenses NLRP3 inflammasome activation by all Gram-negative bacteria. By engaging TRIF, Gram-negative bacteria activate caspase-11. TRIF activates caspase-11 via type I IFN signaling, an event that is both necessary and sufficient for caspase-11 induction and autoactivation. Caspase-11 subsequently synergizes with the assembled NLRP3 inflammasome to regulate caspase-1 activation and leads to caspase-1-independent cell death. These events occur specifically during infection with Gram-negative, but not Gram-positive, bacteria. The identification of TRIF as a regulator of caspase-11 underscores the importance of TLRs as master regulators of inflammasomes during Gram-negative bacterial infection.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1958806, encodeId=51e41958806e6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Nov 05 05:23:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819755, encodeId=27cf1819e55a0, content=<a href='/topic/show?id=a5f999862cd' target=_blank style='color:#2F92EE;'>#革兰氏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99862, encryptionId=a5f999862cd, topicName=革兰氏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Fri Sep 14 19:23:00 CST 2012, time=2012-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868573, encodeId=33ce18685e3b9, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Apr 07 21:23:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320798, encodeId=01291320e98f7, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537601, encodeId=d871153e6010f, content=<a href='/topic/show?id=bde599869c0' target=_blank style='color:#2F92EE;'>#革兰氏阴性菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99869, encryptionId=bde599869c0, topicName=革兰氏阴性菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=790e12885737, createdName=yanghan, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
    2012-11-05 维他命
  2. [GetPortalCommentsPageByObjectIdResponse(id=1958806, encodeId=51e41958806e6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Nov 05 05:23:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819755, encodeId=27cf1819e55a0, content=<a href='/topic/show?id=a5f999862cd' target=_blank style='color:#2F92EE;'>#革兰氏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99862, encryptionId=a5f999862cd, topicName=革兰氏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Fri Sep 14 19:23:00 CST 2012, time=2012-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868573, encodeId=33ce18685e3b9, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Apr 07 21:23:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320798, encodeId=01291320e98f7, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537601, encodeId=d871153e6010f, content=<a href='/topic/show?id=bde599869c0' target=_blank style='color:#2F92EE;'>#革兰氏阴性菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99869, encryptionId=bde599869c0, topicName=革兰氏阴性菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=790e12885737, createdName=yanghan, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
    2012-09-14 whmdzju
  3. [GetPortalCommentsPageByObjectIdResponse(id=1958806, encodeId=51e41958806e6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Nov 05 05:23:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819755, encodeId=27cf1819e55a0, content=<a href='/topic/show?id=a5f999862cd' target=_blank style='color:#2F92EE;'>#革兰氏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99862, encryptionId=a5f999862cd, topicName=革兰氏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Fri Sep 14 19:23:00 CST 2012, time=2012-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868573, encodeId=33ce18685e3b9, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Apr 07 21:23:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320798, encodeId=01291320e98f7, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537601, encodeId=d871153e6010f, content=<a href='/topic/show?id=bde599869c0' target=_blank style='color:#2F92EE;'>#革兰氏阴性菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99869, encryptionId=bde599869c0, topicName=革兰氏阴性菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=790e12885737, createdName=yanghan, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1958806, encodeId=51e41958806e6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Nov 05 05:23:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819755, encodeId=27cf1819e55a0, content=<a href='/topic/show?id=a5f999862cd' target=_blank style='color:#2F92EE;'>#革兰氏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99862, encryptionId=a5f999862cd, topicName=革兰氏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Fri Sep 14 19:23:00 CST 2012, time=2012-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868573, encodeId=33ce18685e3b9, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Apr 07 21:23:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320798, encodeId=01291320e98f7, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537601, encodeId=d871153e6010f, content=<a href='/topic/show?id=bde599869c0' target=_blank style='color:#2F92EE;'>#革兰氏阴性菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99869, encryptionId=bde599869c0, topicName=革兰氏阴性菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=790e12885737, createdName=yanghan, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1958806, encodeId=51e41958806e6, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Mon Nov 05 05:23:00 CST 2012, time=2012-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1819755, encodeId=27cf1819e55a0, content=<a href='/topic/show?id=a5f999862cd' target=_blank style='color:#2F92EE;'>#革兰氏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99862, encryptionId=a5f999862cd, topicName=革兰氏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3860283, createdName=whmdzju, createdTime=Fri Sep 14 19:23:00 CST 2012, time=2012-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868573, encodeId=33ce18685e3b9, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sun Apr 07 21:23:00 CST 2013, time=2013-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1320798, encodeId=01291320e98f7, content=<a href='/topic/show?id=43de6e0076f' target=_blank style='color:#2F92EE;'>#炎症反应#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67007, encryptionId=43de6e0076f, topicName=炎症反应)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b73f484, createdName=lsj628, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1537601, encodeId=d871153e6010f, content=<a href='/topic/show?id=bde599869c0' target=_blank style='color:#2F92EE;'>#革兰氏阴性菌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99869, encryptionId=bde599869c0, topicName=革兰氏阴性菌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=790e12885737, createdName=yanghan, createdTime=Sun Jul 29 08:23:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]